FDA hands a warn­ing let­ter to a Lupin sub­sidiary af­ter fail­ing to main­tain clean­li­ness once again

From In­dia to NJ, the core of the FDA’s in­struc­tions to Lupin sub­sidiary Nov­el Lab­o­ra­to­ries were the same: es­tab­lish prop­er clean­ing and process val­i­da­tion guide­lines …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER